These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26049932)

  • 21. Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing.
    Rehman S; Xu Y; Dunn WB; Day PJ; Westerhoff HV; Goodacre R; Bayat A
    Mol Biosyst; 2012 Sep; 8(9):2274-88. PubMed ID: 22772395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.
    Shih B; Wijeratne D; Armstrong DJ; Lindau T; Day P; Bayat A
    J Hand Surg Am; 2009 Jan; 34(1):124-36. PubMed ID: 19121738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
    Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.
    Iqbal SA; Manning C; Syed F; Kolluru V; Hayton M; Watson S; Bayat A
    Stem Cells Dev; 2012 Mar; 21(4):609-22. PubMed ID: 21612554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
    Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
    Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
    Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
    J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of myofibroblasts in the dermis of patients with Dupuytren's contracture. A possible source for recurrence.
    McCann BG; Logan A; Belcher H; Warn A; Warn RM
    J Hand Surg Br; 1993 Oct; 18(5):656-61. PubMed ID: 8294839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
    Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
    Moyer KE; Banducci DR; Graham WP; Ehrlich HP
    Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
    Nanchahal J; Ball C; Davidson D; Williams L; Sones W; McCann FE; Cabrita M; Swettenham J; Cahoon NJ; Copsey B; Anne Francis E; Taylor PC; Black J; Barber VS; Dutton S; Feldmann M; Lamb SE
    EBioMedicine; 2018 Jul; 33():282-288. PubMed ID: 29983350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease.
    Raykha C; Crawford J; Gan BS; Fu P; Bach LA; O'Gorman DB
    Biochim Biophys Acta; 2013 Oct; 1832(10):1511-9. PubMed ID: 23623986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
    Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture.
    Seyhan H; Kopp J; Schultze-Mosgau S; Horch RE
    Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.